1. Home
  2. GHG vs STRO Comparison

GHG vs STRO Comparison

Compare GHG & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

N/A

Current Price

$1.09

Market Cap

116.0M

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$20.91

Market Cap

381.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
STRO
Founded
2004
2003
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
381.1M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
GHG
STRO
Price
$1.09
$20.91
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$31.33
AVG Volume (30 Days)
6.3K
289.1K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$38,419,000.00
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
N/A
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$0.72
52 Week High
$2.57
$43.85

Technical Indicators

Market Signals
Indicator
GHG
STRO
Relative Strength Index (RSI) 43.37 32.83
Support Level $1.10 $19.11
Resistance Level $1.16 $27.16
Average True Range (ATR) 0.02 1.82
MACD -0.00 -0.21
Stochastic Oscillator 28.57 26.86

Price Performance

Historical Comparison
GHG
STRO

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: